Biotech
LEUVEN, BELGIUM: LEUVEN, BELGIUM -- (Marketwire) -- 09/20/12 -- TiGenix (EURONEXT BRUSSELS: TIG) announced
today that the Company has appointed JeanStéphenne as independent director
and new chairman of the Company� ...
DEERFIELD, IL: DEERFIELD, IL -- (Marketwire) -- 09/19/12 -- Horizon Pharma, Inc. (NASDAQ: HZNP) announced today that it intends to offer and sell, subject to market and other conditions, units in an underwritten pu ...
BURNABY, BRITISH COLUMBIA and TORONTO, ONTARIO: BURNABY, BRITISH COLUMBIA and TORONTO, ONTARIO -- (Marketwire) -- 09/19/12 -- Lifebank Corp. (TSX VENTURE: LBK) and Insception Biosciences Inc announce today that, in accordance with the offer made ...
NEW YORK, NY: Published Abstract Describes Metabolism and Receptor Interactions of Bedtime Cyclobenzaprine Treatment for Fibromyalgia ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 09/19/12 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Charles P. Hart, Ph.D., Threshold's Vice President of Biology, will pre ...
OKLAHOMA CITY, OK: OKLAHOMA CITY, OK -- (Marketwire) -- 09/18/12 -- Cytovance Biologics, a leading full-service contract manufacturer of mammalian and microbial biologics, announced today its receipt of the 2012 CMO Le ...
LONDON, ONTARIO: Last Major Experiments in Preparing for Human Trial Submission ...
CAMBRIDGE, MA: CAMBRIDGE, MA -- (Marketwire) -- 09/18/12 -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, today announced that the U.S. Food and Drug Administration (F ...
ANN ARBOR, MI: Expands Exclusivity for Carmeseal(TM), a First-in-Class, Subcutaneously-Administered Investigational Drug for Duchenne Muscular Dystrophy and Acute Decompensated Heart Failure ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 09/18/12 -- Calyx Bio-Venture Inc. (TSX VENTURE: CYX) announces that the Company's operating subsidiary - Agrisoma Biosciences Inc. ("Agrisom ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 09/17/12 -- Functional Technologies Corp. (TSX VENTURE: FEB)(OTCQX: FEBTF) (the "Company") is pleased to announce the promotion of Dr. John H ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 09/17/12 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that data from a randomized open-label Phase 2b clinical trial of investigational ...
HUDSON, NY: HUDSON, NY -- (Marketwire) -- 09/17/12 -- Taconic and CXR Biosciences Ltd are pleased to announce the publication of two manuscripts describing novel mouse lines humanized for the important drug meta ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 09/14/12 -- Functional Technologies Corp. (TSX VENTURE: FEB)(OTCQX: FEBTF) (the "Company") is pleased to report a successful commercial 2012 ...
CARY, NC: FDA Advisory Committee Voted Against Approval of Lixivaptan for the Treatment of Hyponatremia ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 09/13/12 -- Functional Technologies Corp. (TSX VENTURE: FEB)(OTCQX: FEBTF) (the "Company") is pleased to report that its Phyterra™-branded ...
CAMBRIDGE, MA: Webcast Accessible via Sarepta Therapeutics Website ...
SAN FRANCISCO, CA and TOKYO: SAN FRANCISCO, CA and TOKYO -- (Marketwire) -- 09/13/12 -- Medivation, Inc. (NASDAQ: MDVN) and Astellas Pharma Inc. (TSE: 4503) today announced the availability of XTANDI® (enzalutamide) capsules fo ...
SUGAR LAND, TX: SUGAR LAND, TX -- (Marketwire) -- 09/13/12 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- There is nothing simulated or subconscious about the financial benefit deri ...
